Cargando…
Release of Cell-Free Tumor DNA in the Plasma of Uveal Melanoma Patients Under Radiotherapy
PURPOSE: Uveal melanoma (UM) is a tumor of the eye that metastasizes in approximately half of cases. Prognostic testing requires accessibility to tumor tissue, which is usually not available with eye-preserving therapies. Noninvasive approaches to prognostic testing that provide valuable information...
Autores principales: | Kim, Viktoria, Guberina, Maja, Bechrakis, Nikolaos E., Lohmann, Dietmar R., Zeschnigk, Michael, Le Guin, Claudia H. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599159/ https://www.ncbi.nlm.nih.gov/pubmed/37862025 http://dx.doi.org/10.1167/iovs.64.13.35 |
Ejemplares similares
-
Early detection of metastatic uveal melanoma by the analysis of tumor‐specific mutations in cell‐free plasma DNA
por: Le Guin, Claudia H. D., et al.
Publicado: (2021) -
Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma
por: Francis, Jasmine H., et al.
Publicado: (2022) -
Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome
por: Abbassi, Yasaman Arjmand, et al.
Publicado: (2022) -
Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020) -
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)